Showing 281 - 300 results of 128,762 for search '(( i e decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.12s Refine Results
  1. 281
  2. 282
  3. 283

    The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

    Published 2019
    “…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289

    Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

    Published 2017
    “…Additional images and quantification can found in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1007038#pgen.1007038.s009" target="_blank">S9 Fig</a>. (E) Induction of endogenous <i>hpk-1</i> after <i>daf-15</i> inactivation as measured by qRT-PCR. …”
  10. 290
  11. 291

    At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

    Published 2010
    “…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”
  12. 292
  13. 293
  14. 294
  15. 295

    GRIP1<sup>-/-</sup> platelets do not have decreased velocity in ionophore-stimulated blood vessels. by Kristina L. Modjeski (3123072)

    Published 2016
    “…E) GRIP1<sup>-/-</sup> platelets have a trend toward reduced vWF adhesion in vitro. …”
  16. 296
  17. 297

    Isoflurane decreased miR-214. by Hailiang Yan (284342)

    Published 2013
    “…(<b>E</b>) miR-214 decreased Bax expression in a dose-dependent manner. …”
  18. 298

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Asterisks or “ns” above each column indicate the significance when compared to PBS control (row 1, gray), ATRA (row 2, green), or clodronate (row 3, red) with ANOVA and <i>post-hoc</i> Tukey tests. …”
  19. 299
  20. 300